Here are additional resources on thiamine added on 10-21-2022:
- Links To And Excerpts From “Neurological, Psychiatric, and Biochemical Aspects of Thiamine Deficiency in Children and Adults”
Posted on October 21, 2022 by Tom Wade MD - Links To And Excerpts From The IBCC Chapter, Wernicke’s Encephalopathy
Posted on July 12, 2022 by Tom Wade MD - Vitamin B1 Thiamine Deficiency (Beriberi) from StatPearls, Kimberly D. Wiley; Mohit Gupta. Last Update: June 22, 2020.
- Wernke Encephalopathy – Great Help From Dr Josh Farkas and His Internet Book Of Critical Care
Posted on October 15, 2020 by Tom Wade MD - Whole Blood Thiamine Level From LabCorp With Links To Additional Resources On Thiamine Deficiency
Posted on October 18, 2020 by Tom Wade MD - Wernicke-Korsakoff Syndrome (Thiamine Deficiency) Can Occur In Non-alcoholics As Well As In Alcoholics
Posted on February 15, 2020 by Tom Wade MD - Links To Articles On Vitamin B1 (thiamine), Dementia, And Wernicke Encephalopathy
Posted on December 7, 2019 by Tom Wade MD - A Link To And Excerpts From The Tox and The Hound’s Post On Thiamine Deficiency And Wernicke’s Encephalopathy
Posted on October 31, 2019 by Tom Wade MD - Links To And Excerpts From “Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs” With An Additional Resource
Posted on July 23, 2019 by Tom Wade MD
In this post, I link to and excerpt from Supplemental thiamine as a practical, potential way to prevent Alzheimer’s disease from commencing [PubMed Abstract] [Full-Text] [Full-Text PDF]. Alzheimers Dement (N Y). 2021 Jul 28;7(1):e12199.
The above article has been cited by Association Between Blood Biochemical Factors Contributing to Cognitive Decline and B Vitamins in Patients With Alzheimer’s Disease [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. Front Nutr. 2022; 9: 823573. Published online 2022 Feb 21. doi: 10.3389/fnut.2022.823573
There are 79 similar articles for PMID: 34337137 [Links]
For additional resources on thiamine deficiency, please see
- Beriberi (Thiamine Deficiency) from emedicicine.medscape.com
Updated: Feb 08, 2022
Author: Dieu-Thu Nguyen-Khoa, MD, FACP; - Vitamin B1 (Thiamine) from emedicine.medscape.com
Updated: May 10, 2022
Author: Preeti Dalawari, MD, MSPH, FAAEM, FACEP - thiamine (Rx, OTC) from emedicine.medscape.com
Brand and Other Names: vitamin B1
Classes: B Vitamins; Vitamins, Water-Soluble - Wernicke-Korsakoff Syndrome from emedicine.medscape.com
Updated: May 16, 2018
Author: Glen L Xiong, MD
All that follows is from Supplemental thiamine as a practical, potential way to prevent Alzheimer’s disease from commencing [PubMed Abstract] [Full-Text] [Full-Text PDF]. Alzheimers Dement (N Y). 2021 Jul 28;7(1):e12199.
RESEARCH IN CONTEXT
Can one thiamine tablet a day keep Alzheimer’s away? This article argues that it may do so. The multiple elements that contribute to pathogenesis of Alzheimer’s dementia include mitochondrial depression, increased ROS, lactic acidosis and cerebral acidosis of the brain, cerebral depositions of amyloid and tau, synaptic dysfunction, disturbed neurotransmission, cognitive impairments, and disturbances affecting astrocytes, endothelial cells, and the blood brain barrier. Most of those elements of Alzheimer’s pathogenesis are addressed by thiamine which, if used at a time when a middle‐aged person still has normal cognition, may prevent those components of pathogenesis from developing. In brief: it is easier to prevent Alzheimer’s than to try to reverse it after it has developed. The data supporting the prophylactic use of thiamine are robust. In order to validate its use, a clinical trial is advocated that would enroll persons aged 65 or older who have evidence of depositions of amyloid or tau in their brains, and randomly assign them to take, for as long as 5 years, either thiamine 100 mgs daily or a matched placebo tablet.
Abstract
It is better to attempt stopping Alzheimer’s disease (AD) before it starts than trying to cure it after it has developed. A cerebral scan showing deposition of either amyloid or tau identifies those elderly persons whose cognition is currently normal but who are at risk of subsequent cognitive loss that may develop into AD. Synaptic hypometabolism is usually present in such at‐risk persons. Although inadequate adenosine triphosphate (ATP) may cause synaptic hypometabolism, that may not be the entire cause because, in fact, measurements in some of the at‐risk persons have shown normal ATP levels. Thiamine deficiency is often seen in elderly, ambulatory persons in whom thiamine levels correlate with Mini‐Mental State Examination scores. Thiamine deficiency has many consequences including hypometabolism, mitochondrial depression, oxidative stress, lactic acidosis and cerebral acidosis, amyloid deposition, tau deposition, synaptic dysfunction and abnormal neuro‐transmission, astrocyte function, and blood brain barrier integrity, all of which are features of AD. Although the clinical benefits of administering supplementary thiamine to patients with AD or mild cognitive impairment have been mixed, it is more likely to succeed at preventing the onset of cognitive loss if administered at an earlier time, when the number of aberrant biochemical pathways is far fewer. Providing a thiamine supplement to elderly persons who still have normal cognition but who have deposition of either amyloid or tau, may prevent subsequent cognitive loss and eventual dementia. A clinical trial is needed to validate that possibility.
Keywords: Alzheimer’s, cognitive loss, commencement, early, prevent, thiamine